Measurable Residual Disease in Acute Lymphoblastic Leukemia: Techniques and Therapeutic Utility

H&O Is testing for measurable residual disease (MRD) now a standard component of management of patients with acute lymphoblastic leukemia (ALL)? LM  Measurement of MRD is […]

Circulating Tumor DNA as a Marker of Minimal Residual Disease in Colorectal Cancer

  H&O  How common is recurrence after surgery for nonmetastatic colon cancer? SK  Most patients with stage II or III colon cancer have a risk for […]

Clinical Significance and Management of MRD in Adults With Acute Lymphoblastic Leukemia

  Abstract: Measurable residual disease (MRD) quantification is an essential component of caring for patients with acute lymphoblastic leukemia (ALL). Many studies in pediatric and adult […]